Cytotoxic Flavonoids as Agonists of Peroxisome Proliferator-Activated Receptor γ on Human Cervical and Prostate Cancer Cells

被引:17
作者
Lee, Jee-Young [1 ,2 ]
Kim, Jin-Kyoung [1 ,2 ]
Cho, Min-Chul [1 ,2 ]
Shin, Soyoung [1 ,2 ]
Yoon, Do-Young [1 ,2 ]
Heo, Yong Seok [3 ]
Kim, Yangmee [1 ,2 ]
机构
[1] Konkuk Univ, Dept Biosci & Biotechnol, Seoul 143701, South Korea
[2] Konkuk Univ, Bio Mol Informat Ctr, Seoul 143701, South Korea
[3] Konkuk Univ, Dept Chem, Seoul 143701, South Korea
来源
JOURNAL OF NATURAL PRODUCTS | 2010年 / 73卷 / 07期
关键词
PPAR-GAMMA; NUCLEAR RECEPTORS; FLEXIBLE DOCKING; LIGAND-BINDING; METABOLISM; ALPHA; SELECTIVITY; MINIREVIEW; DISEASE; TARGETS;
D O I
10.1021/np100148m
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
We conducted in silico screening for human peroxisome proliferator-activated receptor gamma (hPPAR gamma) by performing in automated docking study with 450 flavonoids. Among the eight flavonoids is possible agonises of hPPAR gamma, only 3,6-dihydroxyflavone (4) increased the binding between PPAR gamma and steroid receptor coactivator-I (SRC-I), approximately 5-fold, and showed one order higher binding affinity for PPAR gamma than a reference compound, indomethacin. The 6-hydroxy group or the A-ring of 3,6-dihydroxyflavone (4) participated in hydrogen-bonding interactions with the side chain of Tyr327, His449, and Tyr473. The B-ring formed a hydrophobic interaction with Leu330, Leu333, Val339, Ile341, and Met364. Therefore, 3,6-dihydroxyflavone is a potent agonise of hPPAR with cytotoxic effects on human cervical and prostate cancer cells.
引用
收藏
页码:1261 / 1265
页数:5
相关论文
共 37 条
  • [1] The mechanisms of action of PPARs
    Berger, J
    Moller, DE
    [J]. ANNUAL REVIEW OF MEDICINE, 2002, 53 : 409 - 435
  • [2] PPARs: therapeutic targets for metabolic disease
    Berger, JP
    Akiyama, TE
    Meinke, PT
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2005, 26 (05) : 244 - 251
  • [3] Bocher V, 2002, ANN NY ACAD SCI, V967, P7
  • [4] Green Tea: Nature's Defense against Malignancies
    Butt, Masood Sadiq
    Sultan, Muhammad Tauseef
    [J]. CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION, 2009, 49 (05) : 463 - 473
  • [5] Flavonoids: Prospective Drug Candidates
    Cazarolli, Luisa Helena
    Zanatta, Leila
    Alberton, Elga Heloisa
    Reis Bonorino Figueiredo, Maria Santos
    Folador, Poliane
    Damazio, Rosangela Guollo
    Pizzolatti, Moacir Geraldo
    Mena Barreto Silva, Fatima Regina
    [J]. MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2008, 8 (13) : 1429 - 1440
  • [6] Role of the PPAR family of nuclear receptors in the regulation of metabolic and cardiovascular homeostasis: new approaches to therapy
    Chinetti-Gbaguidi, G
    Fruchart, JC
    Staels, B
    [J]. CURRENT OPINION IN PHARMACOLOGY, 2005, 5 (02) : 177 - 183
  • [7] 5-(3,5-Di-tert-butyl-4-hydroxybenzylidene) thiazolidine-2,4-dione modulates peroxisome proliferators-activated receptor γ in 3T3-L1 adipocytes:: Roles as a PPARγ ligand
    Cho, MC
    Lee, WS
    Hong, JT
    Park, SW
    Moon, DC
    Paik, SG
    Yoon, DY
    [J]. MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2005, 242 (1-2) : 96 - 102
  • [8] Peroxisome Proliferators-Activated Receptor (PPAR) Modulators and Metabolic Disorders
    Cho, Min-Chul
    Lee, Kyoung
    Paik, Sang-Gi
    Yoon, Do-Young
    [J]. PPAR RESEARCH, 2008, 2008
  • [9] Dietary phenolics: chemistry, bioavailability and effects on health
    Crozier, Alan
    Jaganath, Indu B.
    Clifford, Michael N.
    [J]. NATURAL PRODUCT REPORTS, 2009, 26 (08) : 1001 - 1043
  • [10] Isocoumarins as estrogen receptor beta selective ligands: Isomers of isoflavone phytoestrogens and their metabolites
    De Angelis, M
    Stossi, F
    Waibel, M
    Katzenellenbogen, BS
    Katzenellenbogen, JA
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2005, 13 (23) : 6529 - 6542